154 related articles for article (PubMed ID: 36348879)
1. Prospect of Alpha-Synuclein (A-Syn) Isolation From Saliva as a Promising Diagnostic Biomarker Alternative in Parkinson's Disease (PD): A Systematic Review.
Muddaloor P; Farinango M; Ansary A; Dakka A; Nazir Z; Shamim H; Jean M; Umair M; Khan S
Cureus; 2022 Oct; 14(10):e29880. PubMed ID: 36348879
[TBL] [Abstract][Full Text] [Related]
2. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
Bougea A; Koros C; Stefanis L
J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of salivary biomarkers in Parkinson's disease.
De Bartolo MI; Belvisi D; Mancinelli R; Costanzo M; Caturano C; Leodori G; Berardelli A; Fabbrini G; Vivacqua G
Neural Regen Res; 2024 Dec; 19(12):2613-2625. PubMed ID: 38595280
[TBL] [Abstract][Full Text] [Related]
5. Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: A systematic review and meta-analysis.
Kharel S; Ojha R; Bist A; Joshi SP; Rauniyar R; Yadav JK
Aging Med (Milton); 2022 Mar; 5(1):53-62. PubMed ID: 35309157
[TBL] [Abstract][Full Text] [Related]
6. Estimation of Alpha-Synuclein Monomer and Oligomer Levels in the Saliva of the Children With Autism Spectrum Disorder: A Possibility for an Early Diagnosis.
Siddique A; Khan HF; Ali S; Abdullah A; Munir H; Ariff M
Cureus; 2020 Aug; 12(8):e9936. PubMed ID: 32968597
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
[TBL] [Abstract][Full Text] [Related]
8. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
Ma LY; Gao LY; Li X; Ma HZ; Feng T
Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
[TBL] [Abstract][Full Text] [Related]
9. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
[TBL] [Abstract][Full Text] [Related]
11. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
[TBL] [Abstract][Full Text] [Related]
12. In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease.
Figura M; Friedman A
Neurol Neurochir Pol; 2020; 54(1):14-20. PubMed ID: 32003440
[TBL] [Abstract][Full Text] [Related]
13. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
Atik A; Stewart T; Zhang J
Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
[TBL] [Abstract][Full Text] [Related]
16. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
Vivacqua G; Latorre A; Suppa A; Nardi M; Pietracupa S; Mancinelli R; Fabbrini G; Colosimo C; Gaudio E; Berardelli A
PLoS One; 2016; 11(3):e0151156. PubMed ID: 27011009
[TBL] [Abstract][Full Text] [Related]
18. The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease.
Garg P; Maass F; Sundaram SM; Mollenhauer B; Mahajani S; van Riesen C; Kügler S; Bähr M
Mol Cell Neurosci; 2022 Jul; 121():103746. PubMed ID: 35660088
[TBL] [Abstract][Full Text] [Related]
19. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
[TBL] [Abstract][Full Text] [Related]
20. Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
Ren J; Pan C; Wang Y; Xue C; Lin H; Xu J; Wang H; Zhang W; Xu P; Chen Y; Liu W
J Neurochem; 2022 Jun; 161(6):506-515. PubMed ID: 35234288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
